Edition:
United Kingdom

Nuevolution Board Of Directors Recommends To Accept Amgen Offer


Wednesday, 22 May 2019 

May 22 (Reuters) - Nuevolution AB (publ) ::STATEMENT BY THE BOARD OF DIRECTORS OF NUEVOLUTION IN RELATION TO THE PUBLIC OFFER FROM AMGEN."OFFER IS FAIR AND WE ARE UNANIMOUS IN DECISION TO RECOMMEND OFFER OF SEK 32.50 PER SHARE.".PERMITTED AMGEN TO CARRY OUT A LIMITED DUE DILIGENCE REVIEW OF NUEVOLUTION IN CONNECTION WITH PREPARATION OF OFFER.THREE LARGEST SHAREHOLDERS IN NUEVOLUTION HAVE UNDERTAKEN TO ACCEPT OFFER.